Development of farnesyltransferase inhibitors for clinical cancer therapy: Focus on hematologic malignancies

Judith E. Karp, Jeffrey E. Lancet

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Development of farnesyltransferase inhibitors for clinical cancer therapy: Focus on hematologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences